Atlas Trials

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Clinical trial NCT03436771 · TERMINATED

Trial details

NCT number
NCT03436771
Sponsor
Juno Therapeutics, a Subsidiary of Celgene
Status
TERMINATED
Study type
OBSERVATIONAL
Non Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic LeukemiaDiffuse Large B Cell LymphomaMantle Cell LymphomaFollicular Lymphoma
Start date
2018-02-19
Primary completion
2018-07-20
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.